Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Molecular Infectious Disease Testing

U.S. Department Of Veterans Affairs·Washington

Molecular Infectious Disease Testing

Closes 11/7/2025$100k – $500kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The VA Puget Sound Health Care System (VAPSHCS) Pathology and Laboratory Medicine Service is requesting reagents for molecular infectious disease testing. The testing is for veterans across Washington State, Oregon, Alaska, and Bone Marrow and Solid Organ Transplant patients tested and monitored from across the United States. The testing includes various viral load and qualitative assays for diseases such as Hepatitis B, Hepatitis C, HIV, and more. The platform uses nucleic acid (NAT) testing analysis/assays. * The testing is for a large volume of random-access molecular analyzers. * The analyzers perform various quantitative and qualitative assays. * The platform uses nucleic acid (NAT) testing analysis/assays. * The testing is for veterans across multiple states and transplant patients. * The contract is for a Cost Per Test Rental (CPT/CPRR) and reagents for a VA-owned molecular instrument.

Attached files

Contact

Hector Gonzalez

[email protected]

Key dates

Opened
10/21/2025
Closes
11/7/2025

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
36C26026Q0048

Budget estimate

$100,000 – $500,000

The budget for this contract can be estimated based on the cost of reagents and supplies for molecular infectious disease testing. The cost of these reagents and supplies can range from $100,000 to $500,000 per year, depending on the volume of testing and the specific reagents required. The contract is for a Cost Per Test Rental (CPT/CPRR) and reagents for a VA-owned molecular instrument, which may also impact the budget. Therefore, the estimated budget range is $100,000 to $500,000.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 68%

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

Iowa State University·Iowa

67% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

67% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

66% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

66% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

U.S. Department Of Energy·Ohio

65% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

University of Massachusetts·Massachusetts

65% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. National Institutes of Health·United States of America

64% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

Massachusetts Department of Public Health·Massachusetts

64% match

RFR 233132 Specialized Laboratory Testing Services

Closes 6/29/2032Opened 3/22/2022

LA County Sheriff·California

64% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

64% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. Department Of Health And Human Services·Maryland

64% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

64% match

RNomics Molecular Standards

Closes 2/14/2027Opened 8/5/2026

U.S. Department Of Health And Human Services·United States of America

64% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

Mental Health, NYS Office of·New York

64% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

63% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

63% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

63% match

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

63% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. Department Of Health And Human Services·Maryland

62% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

62% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

62% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026